Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Apogee Therapeutics, Inc.’s 10-K, filed March 2, 2026.
- Filed
- Mar 2, 2026, 7:20 AM EST
- Fiscal year
- FY2025
- Accession
- 0001974640-26-000002
| Line item | YEAR ENDED DECEMBER 31, 2025 | YEAR ENDED DECEMBER 31, 2024 | YEAR ENDED DECEMBER 31, 2023 |
|---|---|---|---|
| Cash flows from investing activities: | |||
| Purchases of marketable securities | (642,300) | (649,450) | (303,743) |
| Maturities of marketable securities | 467,873 | 350,140 | 30,000 |
| Purchases of property and equipment | (5,147) | (1,152) | (167) |
| Net cash used in investing activities | (179,574) | (300,462) | (273,910) |
| Cash flows from financing activities: | |||
| Proceeds from issuance of common stock and pre-funded warrants, net of issuance costs | 324,052 | 449,955 | 315,391 |
| Proceeds from issuance of common stock under ATM equity offering program, net of issuance costs | 65,582 | 43,528 | — |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Apogee Therapeutics, Inc.'s capex?
- Apogee Therapeutics, Inc. (APGE) reported capex of $62K in Q4 2025.
- What is the long-term trend for Apogee Therapeutics, Inc.'s capex?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s capex has grown at a 455.2% compound annual growth rate (CAGR), from $167K to $5.15M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Apogee Therapeutics, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude